The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
Yearbook members are selected basis their S&P Global 2024 Corporate Sustainability Assessment score
We have big plans across our B2C and B2B businesses in India and abroad
Standalone profit from operations for Q4-2024 were Rs. 108 crore
This will lead to the consolidation and optimization of the company's operations related to the manufacturing of ampoules and vials
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
USFDA inspection at Emcure Pharmaceuticals API facility
Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure
Subscribe To Our Newsletter & Stay Updated
